498 related articles for article (PubMed ID: 30531546)
21. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
[TBL] [Abstract][Full Text] [Related]
22. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis.
Cheung YC; Tsai HP; Lo YF; Ueng SH; Huang PC; Chen SC
Eur Radiol; 2016 Apr; 26(4):1082-9. PubMed ID: 26159872
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of contrast-enhanced spectral mammography compared with MRI for invasive breast cancers: Prospective study in population of predominantly underrepresented minorities.
Lee SC; Hovanessian-Larsen L; Stahl D; Cen S; Lei X; Desai B; Yamashita M
Clin Imaging; 2021 Dec; 80():364-370. PubMed ID: 34509973
[TBL] [Abstract][Full Text] [Related]
25. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
[TBL] [Abstract][Full Text] [Related]
26. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
[TBL] [Abstract][Full Text] [Related]
27. Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China.
Wang Q; Li K; Wang L; Zhang J; Zhou Z; Feng Y
Springerplus; 2016; 5(1):763. PubMed ID: 27386249
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
Zhu X; Huang JM; Zhang K; Xia LJ; Feng L; Yang P; Zhang MY; Xiao W; Lin HX; Yu YH
Clin Breast Cancer; 2018 Oct; 18(5):e985-e995. PubMed ID: 29983379
[TBL] [Abstract][Full Text] [Related]
30. Assessing tumor extent on contrast-enhanced spectral mammography versus full-field digital mammography and ultrasound.
Patel BK; Garza SA; Eversman S; Lopez-Alvarez Y; Kosiorek H; Pockaj BA
Clin Imaging; 2017; 46():78-84. PubMed ID: 28750354
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.
Feng L; Sheng L; Zhang L; Li N; Xie Y
Contrast Media Mol Imaging; 2022; 2022():4224701. PubMed ID: 35585943
[TBL] [Abstract][Full Text] [Related]
32. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
[TBL] [Abstract][Full Text] [Related]
33. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced spectral mammography: comparison with conventional mammography and histopathology in 152 women.
Luczyńska E; Heinze-Paluchowska S; Dyczek S; Blecharz P; Rys J; Reinfuss M
Korean J Radiol; 2014; 15(6):689-96. PubMed ID: 25469079
[TBL] [Abstract][Full Text] [Related]
35. Contrast-Enhanced Spectral Mammography and tumor size assessment: a valuable tool for appropriate surgical management of breast lesions.
Nicosia L; Bozzini AC; Palma S; Montesano M; Signorelli G; Pesapane F; Latronico A; Bagnardi V; Frassoni S; Sangalli C; Farina M; Cassano E
Radiol Med; 2022 Nov; 127(11):1228-1234. PubMed ID: 36149581
[TBL] [Abstract][Full Text] [Related]
36. Classification of contrast-enhanced spectral mammography (CESM) images.
Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance.
Hobbs MM; Taylor DB; Buzynski S; Peake RE
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes.
Phillips J; Miller MM; Mehta TS; Fein-Zachary V; Nathanson A; Hori W; Monahan-Earley R; Slanetz PJ
Clin Imaging; 2017; 42():193-197. PubMed ID: 28107737
[TBL] [Abstract][Full Text] [Related]
39. Contrast Enhanced Spectral Mammography: A Review.
Patel BK; Lobbes MBI; Lewin J
Semin Ultrasound CT MR; 2018 Feb; 39(1):70-79. PubMed ID: 29317041
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
Tang S; Xiang C; Yang Q
Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
